Radioimmunoassays

Global Market Trajectory & Analytics

MCP14331

EXECUTIVE ENGAGEMENTS

POOL

743
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

149
Interactions with Platform & by Email

PARTICIPANTS

32
Unique # Participated

VALIDATIONS

12
Responses Validated*

COMPANIES

44
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

123

PAGES

193

EDITION

9

PRICE

USD 4950

CODE

MCP14331


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Global Radioimmunoassays Market to Reach $485.8 Million by 2026

Amid the COVID-19 crisis, the global market for Radioimmunoassays estimated at US$397.6 Million in the year 2020, is projected to reach a revised size of US$485.8 Million by 2026, growing at a CAGR of 3.3% over the analysis period. Reagents & Kits, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$406.4 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Analyzers segment is readjusted to a revised 1.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $121.9 Million in 2021, While China is Forecast to Reach $86.6 Million by 2026

The Radioimmunoassays market in the U.S. is estimated at US$121.9 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$86.6 Million by the year 2026 trailing a CAGR of 3.1% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

SELECT PLAYERS

Beckman Coulter, Inc.; Berthold Technologies GmbH & Co. KG; Cisbio Bioassays; DiaSorin SpA; Diasource Immunossays S.A; DRG International, Inc.; Euro Diagnostica AB; IBL International GmbH; Izotop ; MilliporeSigma; MP Biomedicals LLC; PerkinElmer, Inc.; Stratec Biomedical AG

SEGMENTS

» Application (Research, Clinical Diagnostics) » End-Use (Hospital, Pharmaceutical Industry, Academics, CROs) » Type (Reagents & Kits, Analyzers)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Radioimmunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Radioimmunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Radioimmunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharmaceutical Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
China Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
China Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Radioimmunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Radioimmunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Radioimmunoassays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
France Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
France Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Radioimmunoassays by End-Use - Hospital, Pharmaceutical Industry, Academics and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospital, Pharmaceutical Industry, Academics and CROs for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2012, 2020 & 2027
Total Companies Profiled: 44

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com